Introduction
There is a group of related neurodegenerative conditions which present as a disturbance of behaviour or language. This has been named frontotemporal dementia (FTD) [1] or frontotemporal lobar degeneration (FTLD) [2] . A division of FTLD into three subgroups is now widely accepted, particularly since the publication 8 years ago of diagnostic consensus criteria [2] . The first subgroup is frontal-variant or behavioural-variant FTD (fvFTD or bvFTD, or confusingly sometimes just FTD), which accounts for about half of FTLD cases [3 ] . The others are progressive nonfluent aphasia (PNFA), and semantic dementia, which often presents as a fluent progressive aphasia, but is due to a deficit of conceptual knowledge rather than of language. The motor syndromes of corticobasal degeneration (CBD), progressive supranuclear palsy (PSP) and motor neurone disease (MND) may also be associated with FTLD features and pathology, and some authorities see these as part of the same spectrum [4 ] .
The pathology of FTLD is heterogeneous. While there are common features (cortical gliosis and laminar spongiosis), a range of histological changes are recognized, most of which are characterized either by intracellular inclusion bodies containing either abnormal forms of the microtubule-associated protein tau, notably familial FTD, Pick body disease (PiD) and the pathologies of CBD and PSP, or by tau-negative, ubiquitin-positive inclusions (FTLD-U).
In this review, we discuss the recent literature in terms of its relevance to four main areas: the current clinical and imaging criteria for diagnosis; our understanding of progressive aphasic syndromes; the relationship between clinical syndrome and pathological diagnosis; and the aetiological role of genetic factors.
Clinical diagnosis
In this section we examine the current clinical and imaging criteria for diagnosis.
Core criteria
A number of recent studies have examined the applicability of the widely used consensus diagnostic criteria [2] . For instance, of 74 patients who eventually met criteria for bvFTD, only one-third showed all five core features at first presentation [5 ] . By contrast, apathy and stereotypic behaviour (which are supportive features) were among the most common initial symptoms, together with impairments of social behaviour, affection and activities of daily living. Another study also found that several of the supportive criteria show strong associations with regional single photon emission computed tomography (SPECT) hypoperfusion on first assessment [6 ] . The joint Sydney-Cambridge studies have highlighted the overlap between behavioural and language variants [7].
In keeping with this, Shinagawa et al. [6 ] found that although anomia and word comprehension difficulty are the most frequent initial features in semantic dementia, social-behavioural changes are frequently present very early. To add further confusion, two groups have emphasized that patients who present with any of the FTLD syndromes -behavioural, semantic, aphasic or extrapyramidal -frequently develop at least one other of these syndromes later in their disease [4 ,8 ] .
Prospective validation of the consensus criteria is still largely lacking. In a very recent study, Knopman et al.
[9 ] reported high sensitivity and specificity for predicting FTLD pathology in a mixed dementia group. They used retrospective clinical data from patients who had come to autopsy, however, rather than prospectively assessing pathology in patients with FTLD diagnoses. Only 30 autopsies were obtained from 129 patients with a clinical FTLD diagnosis, leaving open the possibility for bias: for example, lower mortality in individuals with alternative pathology may have enriched their FTLD sample. Clearly there is a need for further clinico-pathological series.
Amnesia
Despite being an exclusion criterion for FTLD, two independent studies have documented the presence of marked anterograde amnesia as either the sole or dominant symptom in FTLD [9 ,10 ], albeit often joined later by a more typical FTLD syndrome. Moreover, it may be found in up to 40% of pathologically verified FTLD cases whose clinical picture is dominated by the typical behavioural disturbance [9 ] .
The status of episodic memory in semantic dementia is also controversial; such patients have problems recognizing words or faces, and typically perform poorly on memory tests using these materials. Scahill et al. [11 ] have shown that laterality of atrophy is a critical factor: patients with both left and right-predominant atrophy were found to have verbal memory impairment, but those with right-predominant atrophy also had poor memory for faces and geometric figures. Autobiographical memory is also impaired in semantic dementia, with some studies showing a reversal of the typical temporal gradient seen in Alzheimer's disease (i.e. better recall of more recent events in semantic dementia) [12] [13] [14] .
Medial temporal lobe (MTL), and in particular hippocampal, atrophy has now been established as a feature of semantic dementia [15 ] as well as of Alzheimer's disease. Nestor et al. [16 ] recently demonstrated both bilateral hypometabolism (on 18 F-fluorodeoxyglucose positron emission tomography; FDG-PET) and atrophy in the MTL of semantic dementia patients. The crucial difference was the involvement of other limbic regions beyond the MTL (notably the posterior cingulate cortex) in Alzheimer's disease, but not semantic dementia, suggesting that damage in these additional areas is necessary for episodic memory impairment.
Structural imaging
At present, imaging abnormalities are only supportive rather than necessary for a diagnosis of FTLD. In the past we have been happy to diagnose FTLD in the presence of a normal magnetic resonance imaging (MRI) scan, but a recent study casts doubt on this assumption. Using a structured rating scale, all semantic dementia patients had an abnormal scan at presentation (regardless of symptom duration). In contrast, almost half of those meeting clinical criteria for bvFTD were indistinguishable from control scans (C.M. Kipps, R.R. Davies, J. Mitchell, et al., unpublished data). These imaging-normal patients were all male, and had a strikingly better prognosis than their clinically identical but imaging-abnormal counterparts, despite equivalent disease duration at the time of scanning [17] . One possible explanation for this is that the clinical criteria are not specific for patients with a neurodegenerative disease, and are met by patients with neuropsychiatric disorders which can mimic bvFTD.
Recent structural imaging studies in semantic dementia have confirmed that the temporo-polar and perirhinal cortices are the most consistently affected brain regions, and that the degree of atrophy here is correlated with the magnitude of the semantic deficit [18, 19 ] . In PNFA, by contrast, the anterior insula and Broca's area appear to be key regions [20] .
The difficulties in early diagnosis of bvFTD and the potential role of imaging are well illustrated by the report of a patient studied prospectively because of a strong family history of FTLD [21 ] . After almost 4 years she complained of symptoms (stammering, calculation difficulty) or began to show signs (jocularity, laughing inappropriately). At baseline assessment, she demonstrated mild cognitive deficits relative to her premorbid ability (as predicted by the National Adult Reading Test), and mild verbal fluency developed on follow up. Serial MRI scanning showed quantifiable atrophy at clinical onset, implying that underlying disease progression had begun well before any features were noticed.
Functional imaging (metabolic)
In order to use imaging as a diagnostic marker, it is imperative to understand the distribution of changes within the brain at different stages of the disease. The findings of recent studies using SPECT or FDG-PET in bvFTD [22 ,23 ,24,25] have essentially mirrored those of postmortem studies [26 ] . They highlight in particular the involvement of the medial prefrontal cortex, and to a variable degree the posterior orbitofrontal/subcallosal cortex, dorsolateral prefrontal regions and insula. One longitudinal PET study showed metabolic deficits progressing over 1-2 years from the lateral and medial surfaces of the frontal lobe, the caudate, insula and thalamus, to subsequently affect the inferior frontal regions, temporal lobes and inferior parietal cortex [22 ] .
Several studies have examined correlations between regional metabolic changes and behavioural scores [23 ,24] , typically focusing on apathy and disinhibition. The results suggest that damage to the orbitofrontal cortex is associated with both of these clinical features, and that the responsible regions overlap [23 ] . This may explain why both apathy and disinhibition are frequently observed in the same patient depending on environmental circumstances.
Progressive aphasia
In this section we report our understanding of progressive aphasic syndromes.
Classification
It is generally agreed that progressive aphasia is not a unitary entity (though not universally [27] ), but its classification is still a major area of controversy. Most published work assumes an a-priori taxonomy derived from clinical experience, but Knibb et al. [28 ] used cluster analysis to address the question with a minimum of prior assumptions. Restricting their analysis to clinical linguistic features of the syndrome, the results provided independent evidence for the widely held view [2] in which PNFA and semantic dementia are seen as distinct conditions, within the broader rubric of progressive aphasia. Epidemiological support for this conclusion comes from Johnson et al.'s study [3 ] , where PNFA was found to begin after the age of 60 and to affect more women than men, the opposite being true for semantic dementia (and also for bvFTD). On a theoretical level, a growing body of evidence suggests that semantic dementia constitutes a distinct entity, in which neuropsychological impairments spanning various domains are all explained by a single underlying deficit in conceptual category knowledge [29 , 30 ,31 ] .
As the name 'PNFA' suggests, spontaneous speech fluency is the most clinically salient variable distinguishing PNFA and semantic dementia. The word 'fluency' is also used to describe performance in noun generation tasks, and two groups have recently investigated category fluency and initial-letter fluency in progressive aphasia [32 ,33 ] . They found that all patients are impaired on category fluency, but initial-letter fluency is much more abnormal in PNFA than the fluent or semantic group. Letter fluency may therefore be a useful clinical diagnostic tool in patients presenting with progressive aphasia.
Heterogeneity within progressive nonfluent aphasia
Josephs et al. [34 ] emphasize the distinction between progressive disorders of motor speech function -apraxia of speech (AoS) [35] -and progressive aphasia proper. They describe pure progressive AoS, agrammatic progressive aphasia with AoS, and an aphasic group with neither agrammatism nor AoS. In contrast to the usual dominant hemisphere abnormalities described in aphasia, they find that AoS is associated with bilateral atrophy in prefrontal motor areas and the caudate nucleus. This paper highlights the heterogeneity within PNFA, and the clinical value that psycholinguistic expertise can bring to this underexplored field.
Pathology
In 2002, a systematic review by Kertesz et al. [36] found only 59 published cases of progressive aphasia for which pathological information was available, and no large postmortem series of FTLD were published until 2004 [7]. Since then, however, reports have appeared at an astonishing rate, and at the time of writing the total number of cases within clinico-pathological series stands at over 600, with at least nine major studies in the past year alone.
Clinical features and pathology
The distinction between those FTLD pathologies with aggregation of tau protein, and those without, is now firmly established. From this point of view, there are two clinical syndromes which allow confident prediction of pathology. FTLD with MND is always associated with tau-negative FTLD-U [4 , 37 -40 ] , and FTLD with the extrapyramidal features of CBD or PSP is almost always associated with tau-positive pathology [4 , 37 ,38 ,41 ] . Semantic dementia is close behind in its association with FTLD-U [37 ,39 ,41 ,42 ] . By contrast, the pathology in bvFTD and PNFA is much more heterogeneous, and unpredictable. There may be a slight excess of tau-negative pathology in bvFTD [4 , 38 ,39 ] and of tau-positive pathology in PNFA [4 , 28 ,34 , 38 ,39 ] , but not all studies agree [37 ,41 ] (Fig. 1) . The place of Alzheimer's disease pathology in clinical FTLD is hotly debated; three recent papers report a significant proportion of Alzheimer's disease [4 ,41 ] , including one [28 ] in which it accounted for nearly a third of progressive aphasia cases, but other studies have found very few cases [3 , 34 ,37 ] . The resolution of this dilemma awaits further work.
The physical signs of MND, CBD and PSP presumably allow experienced clinicians to diagnose these syndromes confidently, and semantic dementia forms a more consistent clinical syndrome [43] than either PNFA or bvFTD. This hierarchy of clinical consistency is intriguingly parallel to the degree of pathological confidence. PNFA might appear to be an exception -surely quite easy to diagnose? -but perhaps there are pathological and clinical distinctions within this group; Kertesz et al.
[4 ] found that cases of PNFA with Alzheimer pathology have more fluent speech and memory loss at onset than those with FTLD pathologies, and Josephs et al. [34 ] hinted that the presence or absence of apraxia of speech may distinguish tau-positive from tau-negative cases.
Imaging and pathology
The prediction of pathology from imaging findings is difficult, but a small study comparing FTLD-U pathology with PiD and familial FTD (tau exons 10 and 16) suggests that there may be regionally specific radiological differences during life, albeit with substantial overlap between the affected regions. In particular, FTLD-U was associated with asymmetric temporal lobe atrophy (worse on the left), PiD had severe bifrontal volume loss and familial cases tended to have more right medial temporal lobe atrophy [44 ] . The clinical usefulness of these findings remains to be tested.
Prognosis and pathology
A number of studies have compared mortality rates between the different pathological subgroups of FTLD. Patients with MND are at high risk of death from aspiration and related causes, but after excluding this group, most studies have found no difference in mortality between tau-positive and tau-negative cases [4 , 28 ,37 ,41 ,45 ] . The exception is a report by Roberson and colleagues [40 ] , which was designed specifically to answer this question. The clinical part of the study comprised 177 FTLD patients. Semantic dementia and Alzheimer's patients lived for the longest time from onset, followed by progressive aphasics and bvFTD patients in that order. This finding may not extend to the pathology arm of their study as they obtained only 39 FTLD autopsies. Since four of the studies previously cited are larger than this, the difference between taupositive and tau-negative cases may be ascribed to sampling error.
Genetics
In this section we examine the aetiological role of genetic factors.
Heritability
FTLD has a strong genetic component, but only a small proportion of cases show simple Mendelian inheritance. Goldman et al. [46 ] examine this issue in detail, by selecting FTLD pedigrees from their genetic counselling service and stratifying them according to the strength of association of the FTLD syndromes within each pedigree. They found that FTD-MND was the most heritable of the syndromes, though even here only 37% of cases occurred in pedigrees with an autosomal dominant pattern of inheritance, while 41% had no family history. Most of the responsible genes in the pedigrees with an apparent single-gene defect could not be identified on screening for recognized mutations, implying that many loci remain to be described. Semantic dementia was the least heritable syndrome, where 85% of patients lacked any relatives affected by any FTLD syndrome. Similarly, of the 29 cases of FTLD-U described by Godbolt et al. [39 ] , all seven cases with predominantly semantic features lacked a strong family history.
Specific polymorphisms
Two recent studies have identified loci which may be involved in modulating the risk of developing FTLD, or in favouring one FTLD syndrome over another. Examining allele frequencies at the apolipoprotein E locus, Acciarri et al. [47 ] found a difference between progressive aphasic patients and controls; two previous studies [48, 49] found similar results, though each in atypical clinical subgroups. Li et al. [50 ] examined the Met-Val polymorphism of prion protein which is relevant to Creutzfeldt Jakob disease, and found an increased prevalence of the heterozygous (Met-Val) genotype in progressive aphasia.
Conclusion
The most striking area of recent progress in FTLD research is in clinico-pathological correlation, with certain syndromes being closely tied to histopathological subtypes, namely FTD-MND and semantic dementia with FTLD-U, and CBD/PSP with tau-positive inclusions. The pathological basis of bvFTD and PNFA remains unpredictable, but more detailed study of the clinical features may help here. The prognosis seems to depend on the clinical syndrome rather than on the underlying pathology. Strangely, despite the apparently similar pathological substrate, FTD-MND seems to have a strong genetic component while semantic dementia has almost none. One possible interpretation of this is that the presence of ubiquitin inclusions could be an epiphenomenon, rather than being essential to the underlying pathological process.
There appears to be a group of FTLD patients who have a deficit in semantic knowledge associated with anterior temporal lobe atrophy, and this leads to a fluent, anomic aphasia with word comprehension impairment, along with various other nonverbal deficits. In the light of the finding that there are two distinct groups of patients who present with progressive aphasia, distinguished inter alia by fluency, it seems likely that these semantic dementia patients account for at least the majority of fluent progressive aphasics, but this has yet to be firmly established.
The validity of the standard grouping of behavioural, aphasic and semantic syndromes together in FTLD is receiving increasing support on both clinical and pathological levels, although a small proportion of cases still turn out to have Alzheimer pathology -it is not yet clear whether these can be distinguished clinically. The argument for including extrapyramidal tau-positive syndromes such as PSP and CBD in the FTLD classification is also gaining ground. The consensus criteria for the differential diagnosis of these syndromes have been useful in clinical practice and in raising awareness, but have not been supported in detail by recent research work. In our view, the evidence suggests that the core criteria should be broadened and made more flexible, that atrophy as assessed by MRI should be given greater diagnostic weight, particularly in the case of semantic dementia, and that amnesia should no longer be considered an absolute exclusion criterion.
Several important developments have occurred in this field since the time of writing, of which two are particularly significant. Firstly, mutations in the progranulin gene (PGRN) have now been identified as the cause of FTLD-U pathology in a significant proportion of case [51, 52] ; one study suggests 25% of familial cases, and as many as 5% of sporadic case [53] . The precise characterization of individuals with this gene will be very important over the coming year, but there are preliminary suggestions that the clinical phenotype may be quite variable. Secondly, after a major effort, the target of ubiquitination in the neuronal inclusion of FTLD-U has been identified as the DNA-binding protein TDP-43 [54] . Little is known about the precise function of this protein, but that will certainly change over the coming year.
